세계의 의료기기 CDMO 시장 규모, 점유율, 동향 분석 : 제품별, 서비스별, 클래스별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Medical Device CDMO Market Summary

The global medical device CDMO market size was estimated at USD 122.6 billion in 2024 and is projected to reach USD 354.6 billion by 2033, growing at a CAGR of 12.87% from 2025 to 2033. The medical device CDMO market is driven by shifting trends towards outsourcing, rising cost pressures, and increasing need for specialized expertise.

Besides, most manufacturers are increasingly turning to CDMOs to optimize production processes, shorten time-to-market, and gain access to advanced manufacturing capabilities without the financial burden of investing in infrastructure. In addition, growing requirements for a range of medical devices, a trend influenced by an aging population, rising chronic diseases, and a growing shift towards home care and minimally invasive treatments, are anticipated to drive the market. With the changing dynamics in the medical device industry, outsourcing has become a strategic advantage for established and emerging medtech companies.

The market is gaining momentum due to technological advancements that support enhancing efficiency and competitiveness. The integrating digital manufacturing, automation, and advanced materials into production workflows has further improved precision, scalability, and compliance, contributing to market growth. Besides, the rise of additive manufacturing, particularly 3D printing, has facilitated rapid prototyping and the development of tailored device solutions.

Moreover, among medical device market players, data-driven process optimization and IoT-enabled manufacturing systems have enhanced operational efficiency & quality assurance, further creating CDMOs as critical partners in the evolving medtech industry. These innovations have led to rising collaboration among medical device companies and CDMOs, further contributing to market growth. These factors are expected to drive the commercialization of medical technologies and the innovation of new medical devices.

Global Medical Device CDMO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global medical device CDMO market report based on product, service, class, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Diagnostics
• Therapeutics
• Drug-Device Combination Products
• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Contract Development
  • Product Design and Development Services
  • Testing & Validation
  • Quality Management
  • Others
• Contract Manufacturing
  • Accessories Manufacturing
  • Assembly Manufacturing
  • Component Manufacturing
  • Device Manufacturing
• Packaging
• Regulatory Affairs
• Others
• Class Outlook (Revenue, USD Million, 2021 - 2033)
• Class I
• Class II
• Class III
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiovascular Devices
• Orthopedic Devices
• Ophthalmic Devices
• Diagnostic Devices
• Respiratory Devices
• Surgical Instruments
• Dental
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Original Equipment Manufacturers (OEMs)
• Pharmaceutical & Biopharmaceutical Companies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Service
  • 1.2.3. Class
  • 1.2.4. Application
  • 1.2.5. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Top-Down Analysis
  • 1.7.3. Bottom-Up Approach
  • 1.7.4. Multivariate Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Medical Device Contract Development and Manufacturing Organization Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. Tariff Impact Analysis
• 3.6. Value Chain Analysis
  • 3.6.1. Supply Trends
  • 3.6.2. Demand Trends
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Force Analysis
  • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Medical Device Contract Development and Manufacturing Organization Market: Type Estimates & Trend Analysis

• 4.1. Medical Device Contract Development and Manufacturing Organization Market, By Type: Segment Dashboard
• 4.2. Medical Device Contract Development and Manufacturing Organization Market, By Type: Movement Analysis
• 4.3. Medical Device Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
• 4.4. Diagnostics
  • 4.4.1. Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Therapeutics
  • 4.5.1. Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Drug-Device Combination Products
  • 4.6.1. Drug-Device Combination Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Medical Device Contract Development and Manufacturing Organization Market: Service Estimates & Trend Analysis

• 5.1. Medical Device Contract Development and Manufacturing Organization Market, By Service: Segment Dashboard
• 5.2. Medical Device Contract Development and Manufacturing Organization Market, By Service: Movement Analysis
• 5.3. Medical Device Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
• 5.4. Contract Development
  • 5.4.1. Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Product Design and Development Services
    • 5.4.2.1. Product Design and Development Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Testing & Validation
    • 5.4.3.1. Testing & Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Quality Management
    • 5.4.4.1. Quality Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.5. Others
    • 5.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Contract Manufacturing
  • 5.5.1. Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Accessories Manufacturing
    • 5.5.2.1. Accessories Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Assembly Manufacturing
    • 5.5.3.1. Assembly Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. Component Manufacturing
    • 5.5.4.1. Component Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.5. Device Manufacturing
    • 5.5.5.1. Device Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Packaging
  • 5.6.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Regulatory Affairs
  • 5.7.1. Regulatory Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Medical Device Contract Development and Manufacturing Organization Market: Class Estimates & Trend Analysis

• 6.1. Medical Device Contract Development and Manufacturing Organization Market, By Class: Segment Dashboard
• 6.2. Medical Device Contract Development and Manufacturing Organization Market, By Class: Movement Analysis
• 6.3. Medical Device Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Class, 2021 - 2033 (USD Million)
• 6.4. Class I
  • 6.4.1. Class I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Class II
  • 6.5.1. Class II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Class III
  • 6.6.1. Class III Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Medical Device Contract Development and Manufacturing Organization Market: Application Estimates & Trend Analysis

• 7.1. Medical Device Contract Development and Manufacturing Organization Market, By Application: Segment Dashboard
• 7.2. Medical Device Contract Development and Manufacturing Organization Market, By Application: Movement Analysis
• 7.3. Medical Device Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Application, 2021 - 2033 (USD Million)
• 7.4. Cardiovascular Devices
  • 7.4.1. Cardiovascular Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Orthopedic Devices
  • 7.5.1. Orthopedic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Ophthalmic Devices
  • 7.6.1. Ophthalmic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Diagnostic Devices
  • 7.7.1. Diagnostic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Respiratory Devices
  • 7.8.1. Respiratory Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.9. Surgical Instruments
  • 7.9.1. Surgical Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.10. Dental
  • 7.10.1. Dental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.11. Others
  • 7.11.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Medical Device Contract Development and Manufacturing Organization Market: End Use Estimates & Trend Analysis

• 8.1. Medical Device Contract Development and Manufacturing Organization Market, By End Use: Segment Dashboard
• 8.2. Medical Device Contract Development and Manufacturing Organization Market, By End Use: Movement Analysis
• 8.3. Medical Device Contract Development and Manufacturing Organization Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
• 8.4. Original Equipment Manufacturers (OEMs)
  • 8.4.1. Original Equipment Manufacturers (OEMs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Pharmaceutical & Biopharmaceutical Companies
  • 8.5.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Others
  • 8.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Medical Device Contract Development and Manufacturing Organization Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Dashboard
• 9.2. Regional Market Share Analysis, 2024 & 2033
• 9.3. North America
  • 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. Saudi Arabia
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.6. Qatar
    • 9.7.6.1. Key Country Dynamics
    • 9.7.6.2. Competitive Scenario
    • 9.7.6.3. Regulatory Framework
    • 9.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.7. Oman
    • 9.7.7.1. Key Country Dynamics
    • 9.7.7.2. Competitive Scenario
    • 9.7.7.3. Regulatory Framework
    • 9.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Key Participant Categorization
  • 10.1.1. Market Leaders
  • 10.1.2. Emerging Players
• 10.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
• 10.3. Company Profiles
  • 10.3.1. Jabil Inc.
    • 10.3.1.1. Company Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Service Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Thermo Fisher Scientific Inc.
    • 10.3.2.1. Company Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Service Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Integer Holdings Corporation
    • 10.3.3.1. Company Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Service Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. FLEX Ltd.
    • 10.3.4.1. Company Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Service Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. Sanmina Corporation
    • 10.3.5.1. Company Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Service Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. Celestica Inc.
    • 10.3.6.1. Company Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Service Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. Phillips-Medisize
    • 10.3.7.1. Company Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Service Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. Plexus Corp.
    • 10.3.8.1. Company Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Service Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Nipro Corporation
    • 10.3.9.1. Company Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Service Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Viant Technology LLC
    • 10.3.10.1. Company Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Service Benchmarking
    • 10.3.10.4. Strategic Initiatives
  • 10.3.11. West Pharmaceutical Services, Inc.
    • 10.3.11.1. Company Overview
    • 10.3.11.2. Financial Performance
    • 10.3.11.3. Service Benchmarking
    • 10.3.11.4. Strategic Initiatives
  • 10.3.12. Mack Molding
    • 10.3.12.1. Company Overview
    • 10.3.12.2. Financial Performance
    • 10.3.12.3. Service Benchmarking
    • 10.3.12.4. Strategic Initiatives
  • 10.3.13. Cirtec Medical
    • 10.3.13.1. Company Overview
    • 10.3.13.2. Financial Performance
    • 10.3.13.3. Service Benchmarking
    • 10.3.13.4. Strategic Initiatives
  • 10.3.14. Cogmedix
    • 10.3.14.1. Company Overview
    • 10.3.14.2. Financial Performance
    • 10.3.14.3. Service Benchmarking
    • 10.3.14.4. Strategic Initiatives
  • 10.3.15. Synecco Ltd.
    • 10.3.15.1. Company Overview
    • 10.3.15.2. Financial Performance
    • 10.3.15.3. Service Benchmarking
    • 10.3.15.4. Strategic Initiatives
  • 10.3.16. TE Connectivity
    • 10.3.16.1. Company Overview
    • 10.3.16.2. Financial Performance
    • 10.3.16.3. Service Benchmarking
    • 10.3.16.4. Strategic Initiatives
  • 10.3.17. Keller Technology Corp.
    • 10.3.17.1. Company Overview
    • 10.3.17.2. Financial Performance
    • 10.3.17.3. Service Benchmarking
    • 10.3.17.4. Strategic Initiatives
  • 10.3.18. HDA Technology, Inc.
    • 10.3.18.1. Company Overview
    • 10.3.18.2. Financial Performance
    • 10.3.18.3. Service Benchmarking
    • 10.3.18.4. Strategic Initiatives